These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
199 related items for PubMed ID: 2453250
1. Effect of axonal transport blockade on corticotropin-releasing factor immunoreactivity in the median eminence of intact and adrenalectomized rats: relationship between depletion rate and secretory activity. Berkenbosch F, Tilders FJ. Brain Res; 1988 Mar 01; 442(2):312-20. PubMed ID: 2453250 [Abstract] [Full Text] [Related]
2. Hypoglycemia enhances turnover of corticotropin-releasing factor and of vasopressin in the zona externa of the rat median eminence. Berkenbosch F, De Goeij DC, Tilders FJ. Endocrinology; 1989 Jul 01; 125(1):28-34. PubMed ID: 2544403 [Abstract] [Full Text] [Related]
3. Is vasopressin preferentially released from corticotropin-releasing factor and vasopressin containing nerve terminals in the median eminence of adrenalectomized rats? de Goeij DC, Berkenbosch F, Tilders FJ. J Neuroendocrinol; 1993 Feb 01; 5(1):107-13. PubMed ID: 7683555 [Abstract] [Full Text] [Related]
4. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action. Spinedi E, Giacomini M, Jacquier MC, Gaillard RC. Neuroendocrinology; 1991 Feb 01; 53(2):160-70. PubMed ID: 1849620 [Abstract] [Full Text] [Related]
5. Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats. de Goeij DC, Kvetnansky R, Whitnall MH, Jezova D, Berkenbosch F, Tilders FJ. Neuroendocrinology; 1991 Feb 01; 53(2):150-9. PubMed ID: 1849619 [Abstract] [Full Text] [Related]
6. Hypophysial-portal plasma levels, median eminence content, and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin, and oxytocin after pharmacological adrenalectomy. Plotsky PM, Sawchenko PE. Endocrinology; 1987 Apr 01; 120(4):1361-9. PubMed ID: 3030697 [Abstract] [Full Text] [Related]
7. Quantitative immunocytochemistry of corticotropin-releasing factor (CRF). Studies on nonbiological models and on hypothalamic tissues of rats after hypophysectomy, adrenalectomy and dexamethasone treatment. Schipper J, Werkman TR, Tilders FJ. Brain Res; 1984 Feb 13; 293(1):111-8. PubMed ID: 6367890 [Abstract] [Full Text] [Related]
8. Patterns of adrenocorticotropin secretagog release with hypoglycemia, novelty, and restraint after colchicine blockade of axonal transport. Romero LM, Plotsky PM, Sapolsky RM. Endocrinology; 1993 Jan 13; 132(1):199-204. PubMed ID: 7678213 [Abstract] [Full Text] [Related]
9. Immunocytochemical ultrastructural study of hypothalamic neurons containing corticotropin-releasing factor in normal and adrenalectomized rats. Alonso G, Siaud P, Assenmacher I. Neuroscience; 1988 Feb 13; 24(2):553-65. PubMed ID: 3258967 [Abstract] [Full Text] [Related]
10. Effect of hypothalamic norepinephrine depletion on median eminence CRF-41 content and serum ACTH in control and adrenalectomized rats. Weidenfeld J, Feldman S. Brain Res; 1991 Mar 01; 542(2):201-4. PubMed ID: 1851452 [Abstract] [Full Text] [Related]
11. Co-expression of corticotropin-releasing factor and vasopressin immunoreactivity in parvocellular neurosecretory neurons of the adrenalectomized rat. Sawchenko PE, Swanson LW, Vale WW. Proc Natl Acad Sci U S A; 1984 Mar 01; 81(6):1883-7. PubMed ID: 6369332 [Abstract] [Full Text] [Related]
12. Effect of paraventricular lesions on corticotropin-releasing factor (CRF)-like immunoreactivity in the stalk-median eminence: studies on the adrenocorticotropin response to ether stress and exogenous CRF. Bruhn TO, Plotsky PM, Vale WW. Endocrinology; 1984 Jan 01; 114(1):57-62. PubMed ID: 6317350 [Abstract] [Full Text] [Related]
13. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. Science; 1987 Oct 23; 238(4826):524-6. PubMed ID: 2443979 [Abstract] [Full Text] [Related]
14. Immunoreactivity of hypothalamo-neurohypophysial neurons which secrete corticotropin-releasing hormone (CRH) and vasopressin (Vp): immunocytochemical evidence for a correlation with their functional state in colchicine-treated rats. Alonso G, Szafarczyk A, Assenmacher I. Exp Brain Res; 1986 Oct 23; 61(3):497-505. PubMed ID: 3485534 [Abstract] [Full Text] [Related]
15. Corticotrope response to removal of releasing factors and corticosteroids in vivo. Dallman MF, Makara GB, Roberts JL, Levin N, Blum M. Endocrinology; 1985 Nov 23; 117(5):2190-7. PubMed ID: 2995008 [Abstract] [Full Text] [Related]
16. Colchicine treatment differently affects releasable thyrotropin-releasing hormone (TRH) pools in the hypothalamic paraventricular nucleus (PVN) and the median eminence (ME). Alexander K, Nikodémová M, Kucerová J, Strbák V. Cell Mol Neurobiol; 2005 Jun 23; 25(3-4):681-95. PubMed ID: 16075386 [Abstract] [Full Text] [Related]
17. Chronic psychosocial stress enhances vasopressin, but not corticotropin-releasing factor, in the external zone of the median eminence of male rats: relationship to subordinate status. De Goeij DC, Dijkstra H, Tilders FJ. Endocrinology; 1992 Aug 23; 131(2):847-53. PubMed ID: 1322285 [Abstract] [Full Text] [Related]